Elevance Health jumps as CMS boosts 2027 Medicare Advantage payments above expectations
Elevance Health shares are rising after CMS finalized 2027 Medicare Advantage and Part D payment policies on April 6, 2026. The announcement implies a 2.48% payment increase (4.98% when risk-score trends are included), lifting the managed-care group and improving sentiment on 2027 profitability.
1. What’s moving ELV today
Elevance Health (ELV) is up sharply as investors reprice the Medicare Advantage (MA) earnings backdrop after CMS finalized Calendar Year 2027 MA and Part D payment policies on April 6, 2026. The update sparked broad buying across large managed-care names, reflecting relief that the final payment update came in stronger than many feared heading into the release. (cms.gov)
2. The key numbers behind the rally
CMS said the finalized 2027 MA payment update is 2.48% and noted that, when estimated MA risk-score trends are considered, the net payment impact totals 4.98%. That combination—higher revenue per member than the market had been bracing for and clearer visibility into 2027 bids—helped drive a sector-wide sentiment reset that is flowing through to ELV. (beckerspayer.com)
3. Policy details investors are watching
Beyond the headline rate, CMS also finalized payment-accuracy and risk-adjustment-related policy elements, including steps to better align which diagnosis sources count in risk adjustment. Traders are treating the package as a near-term positive for 2027 margins and bidding-season positioning, even as the industry continues to manage elevated medical-cost trends. (cms.gov)
4. The overhang that hasn’t disappeared
Elevance’s Medicare narrative remains complicated by the previously disclosed CMS intent to impose intermediate sanctions related to risk-adjustment data submission requirements, with sanctions previously slated to take effect March 31, 2026. Today’s move appears driven by forward-looking 2027 rate relief rather than a resolution of that enforcement process. (my957.com)